SECTORAL ASSET MANAGEMENT INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
SECTORAL ASSET MANAGEMENT INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$198,569
-98.5%
5,220
-96.4%
0.04%
-98.2%
Q2 2023$13,105,555
+15.2%
143,859
-16.6%
2.18%
-0.1%
Q1 2023$11,377,440
+44.4%
172,490
+13.2%
2.19%
+43.5%
Q4 2022$7,877,501
-7.0%
152,340
+22.9%
1.52%
-8.6%
Q3 2022$8,469,000
+22.2%
123,990
-19.1%
1.67%
+19.5%
Q2 2022$6,930,000
+96.3%
153,250
+120.5%
1.40%
+122.6%
Q1 2022$3,531,000
-5.0%
69,500
+6.9%
0.63%
+139.3%
Q4 2020$3,718,000
-85.2%
65,000
-91.5%
0.26%
-88.6%
Q2 2020$25,103,000
+147.3%
768,609
+102.8%
2.30%
+18.2%
Q1 2020$10,151,000
-27.2%
378,923
-16.8%
1.95%
-6.3%
Q4 2019$13,944,000
-41.9%
455,393
-54.3%
2.08%
-49.8%
Q3 2019$24,017,000
-36.4%
996,983
-33.1%
4.14%
-8.2%
Q2 2019$37,756,000
+12.1%
1,489,957
-13.8%
4.52%
+11.4%
Q1 2019$33,693,000
+17.8%
1,727,829
-20.3%
4.05%
+4.3%
Q4 2018$28,597,000
-21.1%
2,168,115
+6.4%
3.89%
+1.0%
Q3 2018$36,245,000
-5.5%
2,038,516
+17.0%
3.85%
-10.2%
Q2 2018$38,338,000
+5.2%
1,742,622
+5.8%
4.29%
+7.3%
Q1 2018$36,430,000
-4.2%
1,647,692
-6.0%
3.99%
-16.0%
Q4 2017$38,033,0001,752,6554.75%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders